Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node

Cancer Research

Volumn 65, Issue 24, 2005, Pages 11639-11648

  Carrière, Virginie ^a   Colisson, Renaud ^a   Jiguet Jiglaire, Carine ^a   Bellard, Elisabeth ^a   Bouche, Gérard ^a   Al Saati, Talal ^b   Amalric, François ^a   Girard, Jean Philippe ^a   M'Rini, Christine ^a,c  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PADGEM PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HIGH ENDOTHELIAL VENULE; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MELANOMA B16; MICROSCOPY; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SECONDARY LYMPHOID ORGAN; T LYMPHOCYTE; TUMOR DRAINING LYMPH NODE; VENULE;

ANIMALS; ANTIGEN PRESENTATION; CELL ADHESION; CHEMOKINES, CC; ENDOTHELIUM, LYMPHATIC; FEMALE; L-SELECTIN; LEUKOCYTES; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; P-SELECTIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 29244481992     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1190     Document Type: Article

References (54)

1. Marchesi VT, Gowans JL. The migration of lymphocytes through the endothelium of venules in lymph nodes: an electron microscopy study. Proc R Soc Lond B Biol Sci 1964;159:283-90.
2. von Andrian UH. Intravital microscopy of the peripheral lymph node microcirculation in mice. Microcirculation 1996;3:287-300.
3. M'Rini C, Cheng G, Schweitzer C, et al. A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by α(1,3)- fucosyltransferase-IV. J Exp Med 2003;198:1301-12.
4. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
5. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-78.
6. von Andrian UH, M'Rini C. In situ analysis of lymphocyte migration to lymph nodes. Cell Commun Adhes 1998;6:85-96.
7. Mempel TR, Henrickson SE, Von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004;427:154-9.
8. Warnock RA, Askari S, Butcher EC, von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998;187:205-16.
9. Berg EL, Robinson MK, Warnock RA, Butcher EC. The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J Cell Biol 1991;114:343-9.
10. Streeter PR, Rouse BT, Butcher EC. Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988;107:1853-62.
11. Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-57.
12. Okada T, Ngo VN, Ekland E H, et al. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 2002;196:65-75.
13. Gunn MD, Tangemann K, Tam C, et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naïve T lymphocytes. Proc Natl Acad Sci U S A 1998;95:258-63.
14. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of roUing T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med 2000;191:61-76.
15. Campbell JJ, Bowman EP, Murphy K, et al. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3β receptor CCR7. J Cell Biol 1998;141:1053-9.
16. Hamann A, Jablonski-Westrich D, Duijvestijn A, et al. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J Immunol 1998;140:693-9.
17. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999;286:2098-102.
18. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002;3:991-8.
19. Boon T, De Plaen E, Lurquin C, et al. Identification of tumour rejection antigens recognized by T lymphocytes. Cancer Surv 1992;13:23-37.
20. Naito Y, Saito K, Shiiba K, et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998;58: 3491-4.
21. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995;60:183-9.
22. Shankaran V, Ikeda H, Bruce AT, et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107-11.
23. Dighe AS, Richards E, Old LJ, Schreiber, RD. Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFNγ receptors. Immunity 1994;1:447-56.
24. Restifo NP, Antony PA, Finkelstein SE, et al. Assumptions of the tumor 'escape' hypothesis. Semin Cancer Biol 2002;12:81-6.
25. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol 2002;3:999-1005.
26. Poste G, Doll J, Hart IR, Fidler IJ. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 1980;40:1636-44.
27. Stein JV, Soriano SF, M'Rini C, et al. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway. Blood 2003;101:38-44.
28. Maly P, Thall A, Petryniak B, et al. The α(1,3)fucosyl-(1,3) fucosyltransferase Fuc-TVII controls leukocyte rafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996;86:643-53.
29. Luther SA, Bidgol A, Hargreaves DC, et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 2002;169: 424-33.
30. Luther SA, Tang HL, Hyman PL, et al. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A 2000;97:12694-9.
31. von Andrian UH, Chambers JD, Berg EL, et al. L-selectin mediates neutrophil roUing in inflamed venules through sialyl Lewis X-dependent and -independent recognition pathways. Blood 1993;82:182-91.
32. McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:92-9.
33. Bevilacqua MP, Stengelin S, Gimbrone MA, Jr., Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989;243: 1160-5.
34. Ley K, Bullard DC, Arbones ML, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995;181:669-75.
35. Norman KE, Moore KL, McEver RP, Ley K. Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand-1. Blood 1995;86:4417-21.
36. Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 1996;98:1081-7.
37. Hirata T, Furie BC, Furie B. P-, E-, and L-selectin mediate migration of activated CD8+ T lymphocytes into inflamed skin. J Immunol 2002;169:4307-13.
38. Takeuchi H, Fujimoto A, Tanaka M, et al. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004;10: 2351-8.
39. Hjelmstrom P, Fjell J, Nakagawa T, et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am J Pathol 2000;156:1133-8.
40. Christopherson KW, Hood AF, Travers JB, et al. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood 2003;101:801-6.
41. Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181-213.
42. Ley K. The role of selectins in inflammation and disease. Trends Mol Med 2003;9:263-8.
43. Palframan RT, Jung S, Cheng G, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001;194:1361-73.
44. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919-23.
45. Janatpour MJ, Hudak S, Sathe M, et al. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med 2001;194:1375-84.
46. Kobzdej MM, Leppanen A, Ramachandran V, et al. Discordant expression of selectin ligands and sialyl Lewis x-related epitopes on murine myeloid cells. Blood 2002;100:4485-94.
47. Kanamori A, Kojima N, Uchimura K, et al. Distinct sulfation requirements of selectins disclosed using cells that support rolling mediated by all three selectins under shear flow. L-selectin prefers carbohydrate 6-sulfation totyrosine sulfation, whereas p-selectin does not. J Biol Chem 2002;277:32578-86.
48. Kunkel EJ, Dunne JL, Ley K. Leukocyte arrest during cytokine-dependent inflammation in vivo. J Immunol 2000;164:3301-8.
49. Gretz JE, Norbury CC, Anderson AO, et al. Lymphborne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000;192:1425-40.
50. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 2004;6: 297-305.
51. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
52. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96.
53. Di Carlo E, Forni G, Lollini P, et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001;97:339-45.
54. Pekarek LA, Starr BA, Toledano AY, Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med 1995;181:435-40.